Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSSGet Free Report) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and set a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th.

View Our Latest Stock Analysis on Milestone Scientific

Milestone Scientific Stock Up 0.6 %

Shares of MLSS stock opened at $0.93 on Friday. The company’s 50 day moving average is $1.13 and its 200 day moving average is $0.96. Milestone Scientific has a 52-week low of $0.54 and a 52-week high of $1.39. The firm has a market cap of $72.07 million, a price-to-earnings ratio of -13.22 and a beta of 1.41.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of MLSS. Y Intercept Hong Kong Ltd acquired a new stake in Milestone Scientific in the 3rd quarter valued at about $48,000. World Investment Advisors LLC acquired a new stake in shares of Milestone Scientific during the 3rd quarter worth approximately $91,000. Renaissance Technologies LLC increased its holdings in shares of Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after buying an additional 53,198 shares during the last quarter. Carnegie Investment Counsel increased its holdings in shares of Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after buying an additional 27,412 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in shares of Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the last quarter. 5.79% of the stock is owned by hedge funds and other institutional investors.

About Milestone Scientific

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

Featured Stories

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.